China Merchants Securities Co

Nan Hai Corp is selling a bond backed by a standby letter of credit (SBLC) while ENN Energy is returning to the market after a three year hiatus. Meanwhile, waste-to-energy firm China Jinjiang Environment Holding Company (CJE) has mandated a lead for its deal.

China’s Four Seasons Education and Sichuan Hope Education Industry Group are planning to raise as much as $550m between them through IPOs in Hong Kong and the US in 2017, according to a source familiar with the matter.

China Reinsurance Finance Corp added $700m to its existing 2022 bonds through a tap on Wednesday, hitting its $1.5bn regulatory cap.

Kaisa Group Holdings, the only Chinese developer to default on offshore debt back in 2015, started taking bids on Thursday for the new issuance portion of an exchange offer. Four sets of fixed rate notes will be sold to replace the company’s outstanding variable rate senior bonds.

Chinese issuers are dominating Wednesday’s debt market in Asia ex-Japan, with two issuers launching dollar deals and two investment grade corporates announcing roadshows for transactions.

China Reinsurance Finance Corp is looking to tap its 2022 notes issued in March.

Guangzhou Rural Commercial Bank Co got its HK$8.06bn ($1.03bn) Hong Kong IPO away on Wednesday, pricing the shares just below the middle of the offered range.

Guangzhou Rural Commercial Bank Co’s HK$8.34bn ($1.07bn) Hong Kong IPO is covered after three Mainland investors lent their support as cornerstones.

Investors went crazy for WuXi Biologics’ HK$3.9bn ($500.4m) Hong Kong IPO, driving pricing to the top of expectations as hundreds of global accounts poured in.

WuXi Biologics has priced its HK$3.9bn ($500.4m) IPO at the top of guidance after an overwhelming show of demand from institutional and retail investors, according to a banker close to the deal.

Guangzhou Rural Commercial Bank Co has opened books for a HK$8.34bn ($1.07bn) IPO in Hong Kong after a short delay, with Chinese funds anchoring the deal.

Investors threw their weight behind two IPOs in Asia this week, with WuXi Biologics set to price at the top of expectations in Hong Kong and Singapore’s HRnetGroup getting covered across the range.